| 丁贤彬,吕晓燕,焦 艳,等.2021年重庆市恶性肿瘤发病与死亡情况及2016年生存率分析[J].中国肿瘤,2024,33(2):134-139. |
| 2021年重庆市恶性肿瘤发病与死亡情况及2016年生存率分析 |
| Analysis of Cancer Incidence， Mortality in Chongqing in 2021 and Survival Rate in 2016 |
| 投稿时间：2023-05-20 |
| DOI：10.11735/j.issn.1004-0242.2024.02.A008 |
|
 |
| 中文关键词: 恶性肿瘤 发病率 死亡率 生存率 重庆 |
| 英文关键词:cancer incidence mortality survival rate Chongqing |
| 基金项目:重庆市科卫联合项目（2021MSXM198） |
|
| 摘要点击次数: 170 |
| 全文下载次数: 81 |
| 中文摘要: |
| 摘 要：［目的］ 了解重庆市恶性肿瘤发病率、死亡率与5年生存率。［方法］ 采用SPSS 25.0分析重庆市新发恶性肿瘤发病、死亡和随访数据，计算2021年重庆市恶性肿瘤发病率、标化发病率、死亡率、标化死亡率。分别采用2000年第五次人口普查标准人口构成和2000年世界人口构成计算中标率和世标率。采用寿命表法计算观察生存率，乘积极限法(Kaplan-Meier)计算平均生存时间，生存率的比较采用Log-rank法。［结果］ 2021年重庆市恶性肿瘤粗发病率、中标发病率和世标发病率分别为310.50/10万、183.09/10万和196.13/10万，男性标化发病率（196.85/10万）高于女性（170.07/10万）。2021年重庆市恶性肿瘤粗死亡率、中标死亡率和世标死亡率分别为178.88/10万、89.89/10万和103.70/10万，恶性肿瘤标化死亡率男性高于女性、农村高于城市。共计随访74 953人，随访5年恶性肿瘤平均生存时间2.88（2.86～2.90）年。重庆市恶性肿瘤5年生存率为40.34%，女性（49.93%）高于男性（34.04%）（χ2=1 920.842，P<0.001），城市（52.14%）高于农村（34.77%）（χ2=1 692.155，P<0.001）。肺癌、肝癌、食管癌、胃癌、女性乳腺癌、结直肠癌、宫颈癌、前列腺癌、甲状腺癌、子宫体癌5年生存率分别为32.12%、25.82%、29.26%、34.47%、78.95%、54.17%、69.46%、56.93%、93.93%、74.82%。［结论］ 重庆市恶性肿瘤发病率与死亡率较高，但5年生存率较低，应加强肿瘤综合防治，重点应针对男性和农村地区。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence， mortality and 5-year survival rate of cancer in Chongqing. ［Methods］ Data of cancer incidence， mortality and follow-up in Chongqing were collected. The crude incidence， age-standardized incidence rate by Chinese (ASIRC) and world standard population(ASIRW)， crude mortality， age-standardized mortality rate by Chinese (ASMRC) and world standard population(ASMRW) and were analyzed by SPSS 25.0. The observed survival rate of cancer was calculated by survival life table. The average survival life time was calculated by Kaplan-Meier. The 5-year survival rate of cancer between males and females， urban and rural areas was compared by Log-rank. ［Results］ The crude incidence， ASIRC and ASIRW of cancer were 310.50/105，183.09/105 and 196.13/105 in Chongqing in 2021， respectively. ASIRC in male (196.85/105) was significantly higher than that in female(170.07/105). The crude mortality， ASMRC and ASMRW of cancer were 178.88/105， 89.89/105 and 103.70/105 in Chongqing in 2021， respectively. ASMRC of cancer in male was significantly higher than that in female， and ASMRC of cancer in rural areas was higher than that in urban areas. A total of 74 953 cancer cases reported in 2016 were followed up. The average survival time was 2.88 (2.86～2.90) years， and the 5-year survival rate was 40.34%. The 5-year survival rate in female was significantly higher than that in male(49.93% vs 34.04%， χ2=1 920.842， P<0.001). And the 5-year survival rate in urban areas was higher than that in rural areas (52.14% vs 34.77%， χ2=1 692.155，P<0.001). The 5-year survival rate of lung cancer， liver cancer， esophageal cancer， stomach cancer， breast cancer (female)， colorectal cancer， cervical cancer， prostate cancer， thyroid cancer and uterus cancer were 32.12%， 25.82%， 29.26%， 34.47%， 78.95%， 54.17%， 69.46%， 56.93%， 93.93% and 74.82% in Chongqing， respectively. ［Conclusion］ The cancer incidence and mortality of Chongqing in 2021 are relatively high； while the 5-year survival rates of cancers are generally low. The comprehensive prevention and treatment of cancer should be strengthened in Chongqing， particularly for males and rural residents. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |